Kanagawa, Japan

Koichi Miyazaki


 

 

Average Co-Inventor Count = 1.9

ph-index = 8

Forward Citations = 581(Granted Patents)


Location History:

  • Iwatsuki, JP (1998)
  • Ebina, JP (1997 - 2010)
  • Kawasaki, JP (2015)
  • Kanagawa, JP (1990 - 2019)

Company Filing History:


Years Active: 1990-2019

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):

Title: Celebrating the Innovations of Koichi Miyazaki

Introduction

Koichi Miyazaki, a prolific inventor based in Kanagawa, Japan, has made significant contributions to the fields of pharmaceutical science through his innovative spirit. With a remarkable portfolio of 26 patents, he has demonstrated a commitment to enhancing stability and efficacy in drug formulations.

Latest Patents

Among his most recent innovations are two noteworthy patents. The first is a crystalline polymorph of 15β-hydroxy-osaterone acetate, characterized by its improved stability, including storage, pulverization, and absorption characteristics. This crystalline form, identified as Form A, exhibits distinctive diffraction peaks at specific angles of 2θ, and has a melting point ranging from 280 to 283°C, indicating its unique physical properties.

The second patent involves a novel crystalline polymorphic form of ulipristal acetate. This innovation serves as a potential agent for preventing and treating uterine leiomyoma and acts as a contraceptive. The process of producing this crystalline polymorphic form involves dissolving isopropanol-solvated crystals of ulipristal acetate in a mixed solvent containing ethanol and water, successfully crystallizing the compound without using a seed crystal.

Career Highlights

Koichi Miyazaki's career includes tenure at prestigious companies such as Fuji Xerox Co., Ltd. and Teikoku Hormone Manufacturing Co., Ltd. His work in these organizations has allowed him to amalgamate his inventive ideas with practical applications, leading to substantial advancements in pharmaceutical technology.

Collaborations

Throughout his professional journey, Miyazaki has collaborated with talented individuals including Kyoichi Sakakibara and Masaaki Gondo. These partnerships have facilitated a shared exchange of innovative ideas and methodologies that have propelled their research efforts.

Conclusion

Koichi Miyazaki stands out as a dedicated inventor whose patents have the potential to significantly impact the pharmaceutical industry. His latest innovations continue to reflect his passion for creating effective and stable drug solutions, cementing his legacy as an influential inventor in Japan and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…